Breast Screening Navigation
Breast screening looks for disease before symptoms appear. A new lump, nipple discharge or skin change requires diagnostic evaluation instead of simply waiting for a screening mammogram. A provider can help separate those paths, review prior reports and discuss screening based on age and risk. The USPSTF recommends mammography every two years from ages 40 through 74 for the population covered by its guidance; previous breast cancer, high-risk genetic findings and certain other histories need a different plan. An abnormal screening result does not itself diagnose cancer, but it needs a clear next step. This page explains navigation for adults and result review. Mammography, ultrasound, biopsy and specialty treatment are outside services whose access must be confirmed individually.
Symptoms and questions to discuss
- A due or uncertain mammography schedule
- An abnormal or incomplete outside imaging report
- A new breast lump, nipple discharge or skin change
What we check
- Prior mammograms, biopsies and family cancer history
- New symptoms and distinction between screening and diagnosis
- Imaging recommendation, report category and next-step ownership
Treatment options by class
Your provider reviews appropriate options and follow-up based on your assessment.
- Age- and risk-based screening discussion
- Diagnostic imaging navigation for new symptoms
- Outside breast assessment and result follow-through
When we refer
A suspicious finding, persistent unexplained symptom or report recommending biopsy needs outside breast assessment. High-risk histories may warrant a specialized screening plan or genetic counseling. Ask who receives imaging and pathology reports and how an uncompleted next step will be addressed.
Choosing the correct evaluation
Bring prior imaging reports, dates, biopsy findings and the ages at which relatives developed relevant cancers. A provider reviews new symptoms separately from preventive screening. Mammography examines breast tissue; ultrasound may clarify a particular finding, and other imaging is selected for specific indications. Dense breasts can affect interpretation but do not automatically establish a need for every additional test. Confirm the outside facility and the exact study requested before scheduling.
Navigation has defined limits
The initial discussion can explain the reason for an imaging recommendation and the potential for additional views or tissue sampling. Screening has benefits and possible harms, including false alarms and findings requiring further evaluation. This page does not offer cancer treatment, onsite imaging or a biopsy procedure. A provider should clarify what the external service must resolve and what symptoms require an earlier assessment while you await the appointment.
Closing the result loop
Ask when the report should be available and who will explain it. Obtain the actual written recommendation rather than assuming no call means a normal result. Follow-up depends on the finding: additional imaging, a specified interval or biopsy may be advised. Confirm that comparison films and pathology reach the appropriate provider. Report cost, language or scheduling barriers promptly; a screening order is not the same as a completed diagnostic pathway.
New changes and urgent deterioration
Seek prompt assessment for a new lump, spontaneous bloody nipple discharge, nipple inversion or persistent breast skin changes, even after a recent normal mammogram. Redness, warmth, pain or fever may require urgent evaluation for infection. Go directly to emergency care or call 911 for severe systemic illness, confusion, fainting or trouble breathing. Do not delay emergency assessment while arranging imaging, and do not postpone a symptomatic evaluation until your next screening date.
Frequently asked questions
Is a callback a cancer diagnosis?
No. Additional images may clarify an incomplete or uncertain finding. The report should state the recommended next step. Complete that evaluation instead of dismissing the callback or assuming a diagnosis before the investigation is finished.
What if a lump appears after normal screening?
Arrange a diagnostic assessment for the new symptom. A recent screening result does not explain every later change. Tell the provider when the lump appeared and bring the earlier report for comparison.
Do dense breasts always require MRI?
No. Supplemental imaging decisions depend on risk and the individual finding. USPSTF evidence is insufficient to recommend routine supplemental ultrasound or MRI solely for dense breasts after an otherwise negative mammogram. Discuss your situation individually.
What happens after age 74?
Screening decisions after age 74 are individualized because USPSTF evidence is insufficient for a blanket recommendation. Health, preferences and prior history matter. New symptoms require diagnostic assessment regardless of a routine screening schedule.
Who should receive outside reports?
Ask for a named reviewing provider and confirm that imaging, comparison studies and any biopsy report reach that person. If no explanation arrives, contact the team. Do not assume the external facility completed every communication step.
Sources
- Breast Cancer: Screening — United States Preventive Services Taskforce
- Benign and Precancerous Breast Conditions — National Cancer Institute
- Breast Cancer Screening — National Cancer Institute
Content approved by Viva Centers
